Verisante Technology Receives Approval to Sell Products in Australia

Verisante Technology Inc., a Vancouver-based medical device company focused on skin cancer detection technology, announced that it has received regulatory approval to market and sell the Verisante Aura in Australia. Verisante Aura is indicated for use for the evaluation of skin lesions that may be clinically suspicious for melanoma, squamous cell carcinoma and/or basal cell carcinoma. Aura is a non-invasive optical system designed as a tool to aid medical professionals in the assessment of suspect skin lesions for diagnosis as either skin cancer or a benign disorder.

Information summarized from:  Verisante Technology Inc. Press Release